Shares of health-care companies fell amid doubts about the regulatory outlook.
Continue Reading Below
The second push this year to pass a bill replacing the Affordable Care Act appears to have slowed amid criticism of the new bill's provisions.
Biotech indexes are outperforming the broad market for the year to date, a trend that historically has led to growing momentum in the balance of the year, said analysts at J.P. Morgan.
-By Rob Curran, email@example.com
(END) Dow Jones Newswires
May 26, 2017 18:22 ET (22:22 GMT)